Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial.
Konert T, Vogel WV, Paez D, Polo A, Fidarova E, Carvalho H, Duarte PS, Zuliani AC, Santos AO, Altuhhova D, Karusoo L, Kapoor R, Sood A, Khader J, Al-Ibraheem A, Numair Y, Abubaker S, Soydal C, Kütük T, Le TA, Canh NX, Bieu BQ, Ha LN, Belderbos JSA, MacManus MP, Thorwarth D, Hanna GG.
Konert T, et al.
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2235-2243. doi: 10.1007/s00259-019-04421-5. Epub 2019 Jul 31.
Eur J Nucl Med Mol Imaging. 2019.
PMID: 31367906
Free PMC article.
Clinical Trial.